ebomi
Colour theme
Sign in
Insider · CIK 0001687880

Versant Venture Capital VI, L.P.

CIK 0001687880 Name as filed on the most recent filing

Filed as Versant Venture Capital VI, L.P. (51)

186 transaction lines · from 51 filings · filed 2019-06-25 to 2025-10-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

13 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-11-04 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 9,676, disposed Open Form 4 filing 0000899243-20-030580
2020-10-27 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 26,426, disposed Open Form 4 filing 0000899243-20-029546
2020-10-26 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 269,867, disposed Open Form 4 filing 0000899243-20-029546
2020-10-20 P, Open-market purchase Aligos Therapeutics, Inc.ALGS 3,000,000, acquired Open Form 4 filing 0001567619-20-018008
2020-10-19 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 141,513, disposed Open Form 4 filing 0000899243-20-028811
2020-10-16 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 292,520, disposed Open Form 4 filing 0000899243-20-028811
2020-10-15 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 92,496, disposed Open Form 4 filing 0000899243-20-028811
2020-10-14 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 182,031, disposed Open Form 4 filing 0000899243-20-028366
2020-10-13 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 391,984, disposed Open Form 4 filing 0000899243-20-028366
2020-10-12 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 13,243, disposed Open Form 4 filing 0000899243-20-028070
2020-10-09 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 127,933, disposed Open Form 4 filing 0000899243-20-028070
2020-10-08 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 4 lines 616,748, disposed Open Form 4 filing 0000899243-20-028070
2020-10-07 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 934,079, disposed Open Form 4 filing 0000899243-20-027852
2020-10-06 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 601,654, disposed Open Form 4 filing 0000899243-20-027852
2020-08-11 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 250,591, disposed Open Form 4 filing 0000899243-20-022188
2020-08-10 S, Open-market sale Black Diamond Therapeutics, Inc.BDTX 2 lines 205,398, disposed Open Form 4 filing 0000899243-20-022188
2020-06-23 P, Open-market purchase Repare Therapeutics Inc.RPTX 2 lines 5,000,000, acquired Open Form 4 filing 0001209191-20-038990
2020-03-03 P, Open-market purchase Passage BIO, Inc.PASG 4,050,000, acquired Open Form 4 filing 0001209191-20-015670
2020-02-03 P, Open-market purchase Black Diamond Therapeutics, Inc.BDTX 4 lines 16,999,984, acquired Open Form 4 filing 0000899243-20-003371
2020-01-21 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 575,861, disposed Open Form 4 filing 0001104659-20-005671
2020-01-17 S, Open-market sale Akero Therapeutics, Inc.AKRO 223,059, disposed Open Form 4 filing 0001104659-20-005671
2020-01-16 S, Open-market sale Akero Therapeutics, Inc.AKRO 443,483, disposed Open Form 4 filing 0001104659-20-005671
2020-01-15 S, Open-market sale Akero Therapeutics, Inc.AKRO 148,192, disposed Open Form 4 filing 0001104659-20-004440
2020-01-14 S, Open-market sale Akero Therapeutics, Inc.AKRO 246,140, disposed Open Form 4 filing 0001104659-20-004440
2020-01-13 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 235,445, disposed Open Form 4 filing 0001104659-20-004440
2020-01-10 S, Open-market sale Akero Therapeutics, Inc.AKRO 388,794, disposed Open Form 4 filing 0001104659-20-004440
2020-01-09 S, Open-market sale Akero Therapeutics, Inc.AKRO 334,011, disposed Open Form 4 filing 0001104659-20-082855
2020-01-09 S, Open-market sale Akero Therapeutics, Inc.AKRO 334,011, disposed Open Form 4 filing 0001104659-20-002773

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 12
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Versant Venture Capital VI, L.P., insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001687880

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.